Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Analía, Alessio"'
Autor:
Joaquín Solari, Omar Galdame, Lucrecia Rezzonico, Bernardo Frider, Alejandra Villamil, Paola Casciato, María Reig, Juan Carlos Bandi, Analía Alessio, Adrián Gadano
Publikováno v:
Acta Gastroenterológica Latinoamericana, Vol 39, Iss 4, Pp 254-260 (2009)
Introducción. El tratamiento recomendado para los pacientes con hepatitis B crónica HBeAg positivo es PEG interferón alfa 2a durante 48 semanas. No hay suficientes datos que avalen mejor respuesta con 48 semanas de tratamiento versus 24 semanas. E
Externí odkaz:
https://doaj.org/article/b202e237cc0d467388c7c5088fd7974e
Autor:
Bernardo Frider, María Eugenia Buonsante, Jorge Tiscornia, Analía Alessio, Graciela Pellerano
Publikováno v:
Acta Gastroenterológica Latinoamericana, Vol 36, Iss 1, Pp 38-41 (2006)
La porfiria cutánea tarda (PCT) es considerada una manifestación extrahepática de la infección por el virus de la hepatitis C (HCV). La frecuencia de esta asociación es variable y no es claro el mecanismo por el cual el virus la desencadena. Se
Externí odkaz:
https://doaj.org/article/b2426b9fa4f64170ad84ad86a4b41b12
Autor:
Analía Alessio, Bernardo Frider, Veronica Lidia Mathet, Jose Raul Oubiña, Marcia Pozzati, María Luján Cuestas
Publikováno v:
Liver International. 27:727-730
Background: Hepatitis B virus (HBV) immune escape mutants with point mutations within the S gene may arise during the natural course of HBV infection, due to a positive selection pressure exerted by the host immune response. Mutations within the immu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42ece1aee1c0dee8a4e654e3b89337da
https://doi.org/10.1111/j.1478-3231.2007.01480.x
https://doi.org/10.1111/j.1478-3231.2007.01480.x
Autor:
Joaquín, Solari, Omar, Galdame, Lucrecia, Rezzonico, Bernardo, Frider, Alejandra, Villamil, Paola, Casciato, María, Reig, Juan Carlos, Bandi, Analía, Alessio, Adrían, Gadano
Publikováno v:
Acta gastroenterologica Latinoamericana. 39(4)
48 week therapy with peginterferon alfa-2a has demonstrated to be effective in about one third of patients with HBeAg-positive chronic hepatitis B. Although the recommended treatment duration for these patients is 48 weeks, there are no enough data s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e09bf37e94de442dfcb016c5675f22c4
https://pubmed.ncbi.nlm.nih.gov/20178254
https://pubmed.ncbi.nlm.nih.gov/20178254
Autor:
María Luján Cuestas, Daniel Corach, Vanesa Ruiz, Analía Alessio, Andrea Sala, Bernardo Frider, María Laura Minassian, Cintia Wanda Rivero, Marcia Pozzati, Veronica Lidia Mathet, Jose Raul Oubiña
Serum hepatitis B virus (HBV) DNA was extracted from a chronically infected patient with cocirculation of hepatitis B surface antigen (HBsAg) and anti-HBs antibodies. Direct PCR and clone-derived sequences of the S and overlapped P genes were obtaine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::658ac8b294b9cfb127f7a7089f6c038b
https://europepmc.org/articles/PMC1489447/
https://europepmc.org/articles/PMC1489447/
Autor:
Bernardo, Frider, María Eugenia, Buonsante, Jorge, Tiscornia, Analía, Alessio, Graciela, Pellerano
Publikováno v:
Acta gastroenterologica Latinoamericana. 36(1)
Porphyria cutanea tarda (PCT) is considered an extra-hepatic manifestation of HCV infection. The frequency of this association varies according to different authors and the mechanism by which the virus can trigger this disease is not yet clear. We pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::16471e29e46c57f340de9c94ab542d93
https://pubmed.ncbi.nlm.nih.gov/16706076
https://pubmed.ncbi.nlm.nih.gov/16706076